指南与共识糖尿病

自动胰岛素输送:获益、挑战与推荐——欧洲糖尿病研究协会与美国糖尿病协会联合糖尿病技术工作组共识报告

Automated Insulin Delivery: Benefits, Challenges, and Recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association.
指南 / 共识 · Diabetes Care · 2022-01-01

该共识报告由欧洲糖尿病研究协会与美国糖尿病协会联合糖尿病技术工作组制定,综述自动胰岛素输送(AID)系统的当前 landscape 并重点关注其安全性,最后提出一系列推荐的目标行动。工作组由两组织高管联合委托,成员包括两组织提名的作者,经两组织内部审查后发表。

要点

  • AID系统基于传感器葡萄糖数据调节胰岛素泵输送,首个AID系统已获监管批准并进入临床。
  • 部分1型糖尿病患者采用DIY方法利用商业化产品自建AID系统。
  • 工作组对AID系统安全性进行重点综述并提出针对性推荐行动。

核心结论

  • 工作组综述AID系统现状并重点关注安全性,最后提出一系列推荐的目标行动。

研究设计与样本

  • 由欧洲糖尿病研究协会与美国糖尿病协会联合糖尿病技术工作组制定的共识报告。
  • 工作组由两组织高管联合委托,初始作者组由美国糖尿病协会提名3名成员与欧洲糖尿病研究协会提名3名成员组成。
  • 后续增加作者以提升多样性与专业范围,每篇稿件经两组织内部审查后由两期刊编辑审阅。

主要发现

  • 过去10年可整合入临床诊疗的设备大幅增长。
  • 基于可靠的持续葡萄糖监测系统,胰岛素泵输送可根据传感器葡萄糖数据进行调节。
  • 首个AID系统已获监管批准并被临床采用。
  • 部分1型糖尿病患者通过DIY方法利用商业化产品自建系统。
  • 多个AID系统正在开发中,部分预计不久将获监管批准。

临床怎么用

  • 原文未据此给出具体推荐条款。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A technological solution for the management of diabetes in people who require intensive insulin therapy has been sought for decades. The last 10 years have seen substantial growth in devices that can be integrated into clinical care. Driven by the availability of reliable systems for continuous glucose monitoring, we have entered an era in which insulin delivery through insulin pumps can be modulated based on sensor glucose data. Over the past few years, regulatory approval of the first automated insulin delivery (AID) systems has been granted, and these systems have been adopted into clinical care. Additionally, a community of people living with type 1 diabetes has created its own systems using a do-it-yourself approach by using products commercialized for independent use. With several AID systems in development, some of which are anticipated to be granted regulatory approval in the near future, the joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association has created this consensus report. We provide a review of the current landscape of AID systems, with a particular focus on their safety. We conclude with a series of recommended targeted actions. This is the fourth in a series of reports issued by this working group. The working group was jointly commissioned by the executives of both organizations to write the first statement on insulin pumps, which was published in 2015. The original authoring group was comprised by three nominated members of the American Diabetes Association and three nominated members of the European Association for the Study of Diabetes. Additional authors have been added to the group to increase diversity and range of expertise. Each organization has provided a similar internal review process for each manuscript prior to submission for editorial review by the two journals. Harmonization of editorial and substantial modifications has occurred at both levels. The members of the group have selected the subject of each statement and submitted the selection to both organizations for confirmation.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Sherr JL, Heinemann L, Fleming GA, et al. Automated Insulin Delivery: Benefits, Challenges, and Recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association. Diabetes Care. 2022. PMID: 36202061. doi:10.2337/dci22-0018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。